We are live on ! Find out more
IART icon

Integra LifeSciences
IART

236 hedge funds and large institutions have $2.88B invested in Integra LifeSciences in 2017 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 95 increasing their positions, 73 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

87% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 23

30% more repeat investments, than reductions

Existing positions increased: 95 | Existing positions reduced: 73

6% more funds holding

Funds holding: 223 → 236 (+13)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

3% less capital invested

Capital invested by funds: $2.96B → $2.88B (-$86M)

66% less call options, than puts

Call options by funds: $653K | Put options by funds: $1.92M

94.42% less ownership

Funds ownership: 185.69% → 91.27% (-94%)

Holders
236
Holders Change
+13
Holders Change %
+5.83%
% of All Funds
5.88%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
43
Increased
95
Reduced
73
Closed
23
Calls
$653K
Puts
$1.92M
Net Calls
-$1.27M
Net Calls Change
-$11.2M

Top Buyers

1
BlackRock
BlackRock
New York
+$318M
2
GT
Glenmede Trust
Pennsylvania
+$47.9M
3
JHIU
Janus Henderson Investors US
Colorado
+$46.3M
4
Millennium Management
Millennium Management
New York
+$32.5M
5
Jennison Associates
Jennison Associates
New York
+$26.5M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$126M
2
Wells Fargo
Wells Fargo
California
-$73.3M
3
Capital Research Global Investors
Capital Research Global Investors
California
-$28.7M
4
Neuberger Berman Group
Neuberger Berman Group
New York
-$19.6M
5
MFIMFI
Mesirow Financial Investment Management - Fixed Income
Illinois
-$19M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$321M -$126M -2,956,464 -28%
BlackRock
2
BlackRock
New York
$314M +$318M +7,450,720 +153,813%
Vanguard Group
3
Vanguard Group
Pennsylvania
$238M +$18.7M +436,928 +8%
CIP
4
Champlain Investment Partners
Vermont
$187M +$21.3M +497,530 +13%
Wells Fargo
5
Wells Fargo
California
$104M -$73.3M -1,716,178 -41%
JHIU
6
Janus Henderson Investors US
Colorado
$88.8M +$46.3M +1,083,535 +106%
Dimensional Fund Advisors
7
Dimensional Fund Advisors
Texas
$70.7M -$1.29M -30,103 -2%
Invesco
8
Invesco
Georgia
$67.4M -$60.2K -1,409 -0.1%
State Street
9
State Street
Massachusetts
$63.1M +$4.86M +113,809 +8%
Millennium Management
10
Millennium Management
New York
$59.3M +$32.5M +760,876 +118%
Victory Capital Management
11
Victory Capital Management
Texas
$54.3M -$6.4M -149,680 -10%
ClearBridge Investments
12
ClearBridge Investments
New York
$54.2M +$476K +11,149 +0.9%
Capital Research Global Investors
13
Capital Research Global Investors
California
$50.2M -$28.7M -671,000 -36%
EAM
14
Eagle Asset Management
Florida
$49.9M +$8.08M +189,049 +19%
GT
15
Glenmede Trust
Pennsylvania
$47.3M +$47.9M +1,120,597 +33,631%
Goldman Sachs
16
Goldman Sachs
New York
$45.9M -$5.26M -123,166 -10%
Fisher Asset Management
17
Fisher Asset Management
Washington
$43.4M -$485K -11,350 -1%
Royal Bank of Canada
18
Royal Bank of Canada
Ontario, Canada
$37.2M +$826K +19,330 +2%
VNIM
19
Vaughan Nelson Investment Management
Texas
$37.1M +$10.9M +254,825 +41%
Northern Trust
20
Northern Trust
Illinois
$35.4M -$1.52M -35,540 -4%
HRCM
21
Hood River Capital Management
Florida
$33.4M +$1.16M +27,041 +4%
Bank of New York Mellon
22
Bank of New York Mellon
New York
$32.5M -$15.3M -357,780 -32%
Boston Partners
23
Boston Partners
Massachusetts
$31.7M -$146K -3,425 -0.5%
ACM
24
Atlanta Capital Management
Georgia
$29.9M +$1.61M +37,773 +6%
Westfield Capital Management
25
Westfield Capital Management
Massachusetts
$28.8M -$541K -12,667 -2%
1
2 3 4 5

IART Hedge Fund Activity: Q1 2017 in Review

236 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q1 2017, worth a combined $2.88B — down 2.9% from $2.96B a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new IART positions and 23 closed out — a net gain of 20 holders — while 95 added to existing stakes and 73 trimmed.

The largest buyer was BlackRock, adding an estimated $318M. The largest seller was Fidelity Investments, cutting an estimated $126M.

  • 236 institutional investors held Integra LifeSciences (IART) as of Q1 2017, up from 223 in Q4 2016.
  • Funds reported $2.88B of Integra LifeSciences stock for Q1 2017, down 2.9% quarter-over-quarter.
  • 43 funds opened new Integra LifeSciences positions in Q1 2017 and 23 closed out, a net change of +20 holders.
  • The largest Integra LifeSciences buyer in Q1 2017 was BlackRock, an estimated $318M added.
  • The largest Integra LifeSciences seller in Q1 2017 was Fidelity Investments, an estimated $126M sold.

Based on aggregated 13F filings for Q1 2017.